Chi Teng Vong

2.9k citations
55 papers · 2.2k indexed · 3 hit papers · h-index 25

Chi Teng Vong

55 papers receiving 2.2k citations

Hit Papers

Turmeric-derived nanovesicles as novel nanobiolog...1752019202620212023100200300400

Peers

Chi Teng Vong
Comparison fields: 5 of 116
  • Complementary and alternative medicine 309
  • Pharmacology 306
  • Molecular Biology 1.0k
  • Toxicology 50
  • Pharmacology 230
Replace Wen‐Chung Huang with:
Wen‐Chung Huang Taiwan
Xiangchun Shen China
Hwan‐Suck Chung South Korea
Zhifeng Wei China
Sadiq Umar India
Abdul Quaiyoom Khan Qatar
Chian‐Jiun Liou Taiwan
Minghai Tang China
Jie Song China
Yao Li China
Chi Teng Vong relative to Wen‐Chung Huang Taiwan Wen‐Chung Huang's profile →
Citations per field
00.5×1.7×
Wen‐Chung Huang · 1×
Citations per year

Countries citing papers authored by Chi Teng Vong

Since Specialization
Citations

This map shows the geographic impact of Chi Teng Vong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi Teng Vong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi Teng Vong more than expected).

Fields of papers citing papers by Chi Teng Vong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi Teng Vong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi Teng Vong. The network helps show where Chi Teng Vong may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Chi Teng Vong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chi Teng Vong Line = papers co-authored together Chi Teng Vong links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20254
2 20241
3 20242
4 202415
5 20246
6 20241
7 202421
8 20241
9 202310
10 202235
11 202216
12 20226
13 202279
14 20229
15 202276
16 202123
17 202133
18 202011
19 202028
20 2020120

About Chi Teng Vong

Chi Teng Vong is a scholar working on Pharmacology, Complementary and alternative medicine and Pharmacology, having authored 55 papers that have together received 2.2k indexed citations. Recurring topics across this work include Pharmacological Effects of Natural Compounds (13 papers), Ginseng Biological Effects and Applications (7 papers), Berberine and alkaloids research (6 papers), Pancreatic function and diabetes (6 papers), Traditional Chinese Medicine Analysis (4 papers), Inflammasome and immune disorders (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Chromatography in Natural Products (3 papers). The work is most often cited by research in Complementary and alternative medicine (309 citations), Pharmacology (306 citations) and Molecular Biology (1.0k citations). Chi Teng Vong has collaborated with scholars based in Macao, China and Hong Kong. Frequent co-authors include Caifang Gao, Yitao Wang, Yitao Wang, Shengpeng Wang, Shengpeng Wang, Zhejie Chen, Peifen Yao, Zhangfeng Zhong, Hua Luo and Maggie Pui Man Hoi. Their work appears in journals such as Cell Metabolism, Scientific Reports and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026